
Khusrow A Niazi MD
Adult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine
Associate Professor, Medicine, Emory University School of Medicine
Join to View Full Profile
1364 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-8240
Fax+1 404-778-0560
Dr. Niazi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Corewell Health William Beaumont University HospitalFellowship, Cardiovascular Disease, 1988 - 1992
- Kettering Health Network/Kettering Medical CenterResidency, Internal Medicine, 1984 - 1988
- Kettering Health NetworkResidency, Pathology-Anatomic and Clinical, 1982 - 1984
- King Edward Medical UniversityClass of 1981
Certifications & Licensure
- ID State Medical License 2002 - Present
- GA State Medical License 1996 - 2025
- IN State Medical License 1984 - 2025
- FL State Medical License 1991 - 2006
- MI State Medical License 1988 - 2004
- WA State Medical License 2002 - 2003
- OH State Medical License 1985 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study.Tanja Böhme, Thomas Zeller, Mehdi H Shishehbor, Martin Werner, Marianne Brodmann
Journal of Endovascular Therapy. 2025-04-01 - Stellarex Drug-Coated Balloon for the Treatment of Peripheral Artery Disease: Five-Year Results from the ILLUMENATE Pivotal Randomized Controlled Trial.Prakash Krishnan, Peter Faries, Khusrow Niazi, Ravish Sachar, Ash Jain
The American Journal of Cardiology. 2024-09-15 - 7 citationsNo Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.Sean P Lyden, Peter L Faries, Khusrow A K Niazi, Ravish Sachar, Ash Jain
Journal of Endovascular Therapy. 2022-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: